Bulevirtide FDA Approval Status
FDA Approved: No
Generic name: bulevirtide
Company: Gilead Sciences, Inc.
Treatment for: Hepatitis D
Bulevirtide is a novel virion entry inhibitor in development for the treatment of adults with chronic hepatitis delta virus (HDV) infection.
Development timeline for bulevirtide
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.